Patients with heart failure need specialist care

(Medical Xpress)—New research from Karolinska Institutet in Sweden shows that patients with heart failure have high mortality and often are undertreated. According to a study, published in the scientific periodical JACC, many more of these patients would benefit from advanced treatment by heart specialists - something that could be decided by a simple evaluation of five common risk factors for early death due to heart failure.

Heart failure affects 2-3% of the overall population and over 10% of the elderly worldwide, and is associated with high risk for and reduced quality of life. Drug therapy improves symptoms and reduces mortality and is well used. However, modern heart failure pacemakers, heart pumps and also heart transplantation are of great benefit in selected , but are poorly utilized. Earlier studies have shown that, a major reason is that heart failure patients are generally cared for by generalist doctors with limited awareness of these treatments.

In the present study, a team comprising researchers at Karolinska Institutet, Linköping University, Stockholm South General Hospital and Karolinska University Hospital analysed data from 10,000 patients from the large Swedish Heart Failure Registry. First researchers showed that early death in these patients was related to heart failure (rather than for example age) suggesting that better treatment for heart failure would reduce mortality.

Second, the researchers defined 5 for mortality: poor pump capacity, poor kidney function, low blood count and absent treatment with the drugs ACE inhibitors and beta blockers. If any one of these risk factors was present in a given patient, the mortality was so high that the patient would potentially benefit from a heart failure pacemaker, heart pump and heart transplantation. This risk persisted after adjustment for a large number of other factors, such as patients' age, general health and other factors.

"Currently, less than 5% of patients with heart failure receive heart failure pacemakers and many fewer receive heart pumps or transplantation. Our findings suggest that many more need these treatments and should be referred to specialists for evaluation", says study leader Dr Lars H. Lund of Karolinska Institutet.

More information: Thorvaldsen, T. et al. Triage of Patients with Moderate to Severe Heart Failure: Who Should be Referred to a Heart Failure Center? Journal of the American College of Cardiology (JACC), online 25 October 2013. DOI: 10.1016/j.jacc.2013.10.017

add to favorites email to friend print save as pdf

Related Stories

Common heart failure drugs could benefit more patients

Nov 27, 2012

A novel study from Karolinska Institutet in Sweden suggests that commonly used drugs to treat heart failure and high blood pressure may have a wider range of application than earlier known, and also can be used against so ...

Pacemaker could help more heart failure patients

Oct 05, 2012

(Medical Xpress)—A new study from Karolinska Institutet demonstrates that a change in the ECG wave called the QRS prolongation is associated with a higher rate of heart-failure mortality. According to the team that carried ...

Nerve stimulation in neck may reduce heart failure symptoms

Oct 30, 2013

A multidisciplinary team of experts in heart failure, cardiac arrhythmia, and neurosurgery at The Mount Sinai Hospital are now testing nerve stimulation in the neck as a novel therapy for heart failure patients to potentially ...

Recommended for you

Huge discrepancies on heart disease in Europe

10 hours ago

Russians and Ukrainians aged 55 to 59 die from coronary heart disease at a higher rate than Frenchmen who are 20 years older, a study released Wednesday of Europe's cardiovascular health showed.

Common antibiotic linked with heart deaths

20 hours ago

The antibiotic clarithromycin—widely used for treating common bacterial infections—is associated with an increased risk of heart deaths, finds a study published in the BMJ today.

User comments